Info Sheets
Navigate the full CKM continuum with a single, integrated nonclinical partner. Labcorp provides coordinated cardiovascular safety, metabolic and incretin based pharmacology, GI and tolerability assessments, biomarkers, bioanalysis, and regulatory guidance. By unifying data across disciplines and aligning nonclinical strategy with downstream clinical and biomarker planning, we help you generate decision grade evidence earlier, reduce development risk, and maintain momentum in today’s highly competitive cardiometabolic landscape.